Magnitude of the Potential Screening Gap for Fabry Disease in Manitoba: A Population-Based Retrospective Cohort Study

Background: Fabry disease is a rare disorder caused by the deficient activity of α-galactosidase A (GLA) that often leads to organ damage. Fabry disease can be treated with enzyme replacement or pharmacological therapy, but due to its rarity and nonspecific manifestations, it often goes undiagnosed....

Full description

Bibliographic Details

Published in:	Canadian Journal of Kidney Health and Disease
Main Authors:	Reid H. Whitlock, Mohammad Nour-Mohammadi, Sarah Curtis, Paul Komenda, Clara Bohm, David Collister, Navdeep Tangri, Claudio Rigatto
Format:	Article
Language:	English
Published:	SAGE Publishing 2023-03-01
Online Access:	https://doi.org/10.1177/20543581231162218